| Description |
1 online resource (281 pages) |
| Contents |
Chapter 1: Gut-Brain Axis: Role in Hunger and Satiety -- Chapter 2: Antiobesity Activities of Probiotics and Dairy based Ingredients -- Chapter 3: Effect of Pre/Probiotic Supplementation on Metabolic Endotoxemia -- Chapter 4: Probiotics in the management of Diabetes -- Chapter 5: Intestinal microbiota modulation for type 1 and type 2 diabetes prevention -- Chapter 6: Mechanisms of beneficial effects of probiotics in diabetes mellitus -- Chapter 7: Preventive and therapeutic role of Probiotics in type- 2 diabetes and its associated complications -- Chapter 8: Protective effect of probiotic in alcohol induced liver disorders -- Chapter 9: Molecular Mechanism of Beneficial Effects of Probiotics in Alcohol-Induced Liver Disorder -- Chapter 10: Effect of probiotic supplementation on modulation of serum lipids -- Chapter 11: Use of prebiotics for addressing gut dysbiosis and achieving healthy gut- brain axis -- Chapter 12: Designer Probiotics in Metabolic Disorders -- Chapter 13: Animal models used for studying the benefits of probiotics in metabolic disorders |
| Summary |
This volume focuses on the potential use of probiotics in treating metabolic disorders such as diabetes mellitus, metabolic acidosis, and gut dysbiosis. Chapters draw an association between gut microbiota and its diversity with metabolic diseases like diabetes, obesity, related liver and gut disorders; gut-brain axis; increased inflammation, and a compromised immune system resulting from these manifestations and scope of intervention with probiotics. Special attention is laid on describing the mechanisms of action of such beneficial effects of probiotic administration. The ability of probiotics to decrease metabolic endotoxemia by restoring the disrupted intestinal mucosal barrier is also included. The volume is a comprehensive compilation describing the scope and application of probiotic and prebiotic therapy in treating metabolic disorders. Readers will discover how probiotics are not just confined to the microbiology industry but are showing promising results in the medical and pharmaceutical sectors |
| Notes |
Online resource; title from PDF title page (SpringerLink, viewed May 12, 2022) |
| Subject |
Probiotics.
|
|
Gastrointestinal system -- Microbiology.
|
|
Nervous system -- Degeneration.
|
|
Pharmaceutical technology.
|
|
Gastrointestinal system -- Microbiology
|
|
Nervous system -- Degeneration
|
|
Pharmaceutical technology
|
|
Probiotics
|
| Form |
Electronic book
|
| Author |
Kaur, Indu Pal, 1965- editor.
|
|
Chopra, Kanwaljit, editor
|
|
Bishnoi, Mahendra, editor
|
|
Kondepudi, Kanthi Kiran, editor
|
| ISBN |
9789811684449 |
|
9811684448 |
|
